gemcitabine has been researched along with glutamic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ding, N; Gou, J; He, H; Tang, X; Wang, Y; Xu, Y; Yin, N; Yin, T; Zhang, Y; Zhao, Z | 1 |
Bai, O; Guo, W; Liu, Z; Song, W; Tang, Z; Wang, S; Yu, H; Zhang, D | 1 |
2 other study(ies) available for gemcitabine and glutamic acid
Article | Year |
---|---|
Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Deoxycytidine; Drug Carriers; Drug Compounding; Drug Liberation; Gemcitabine; Glutamic Acid; Humans; Male; Mice; Micelles; Polyethylene Glycols; Prodrugs; Rats; Xenograft Model Antitumor Assays | 2021 |
Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Polyethylene Glycol Complex Nanoparticles Combined with Gemcitabine Presents Improved Safety and Lasting Anti-Tumor Efficacy in a Murine Xenograft Model of Human Aggressive B Cell Lymphoma.
Topics: Animals; Animals, Outbred Strains; Cisplatin; Deoxycytidine; Gemcitabine; Glutamic Acid; Heterografts; Humans; Lymphoma, B-Cell; Mice; Mice, SCID; Nanoparticles; Polyethylene Glycols | 2021 |